RE: Real nice board7 Oct 2020 18:02
Newbie - unlike any of the competition there is a real possibility that this, handheld 90? Second test could be adapted & used with many future virus/disease etc.
We’re yet to have this confirmed at any meaningful level but as others said earlier in the day Carl’s posts on twitter really do add a large level of confidence For us holders.
Confirmation on adaption, partners, joint ventures, government funding, buy out or whatever it may be £3 would only be around £120m mcap from this level.
In comparison to other tests, which wouldn’t be as good, doesn’t seem So much of a pipe dream. Imo. But we’ll see.